Loading...
Loading...
LataMed AI Corp.
LataMed AI Corp.. Spoken Alpha tracks LMED's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks LMED's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 60% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for LMED.
curl https://api.spokenalpha.com/v1/companies/LMED| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $2.51 | $1.83 | +37.1% | +0.2% | -1.7% |
| Q4 FY2026 | $2.46 | $1.72 | +42.9% | +1.2% | +1.7% |
| Q3 FY2026 | $2.72 | $1.86 | +46.4% | +1.7% | +3.3% |
| Q2 FY2026 | $2.52 | $1.89 | +33.3% | +2.0% | +0.6% |
| Q1 FY2025 | $2.69 | $1.85 | +45.2% | -2.6% | +0.3% |
| Q4 FY2025 | $2.71 | $1.91 | +41.8% | -6.0% | -7.5% |
| Q3 FY2025 | $2.68 | $1.98 | +35.3% | +3.9% | +3.8% |
| Q2 FY2025 | $2.64 | $1.85 | +42.9% | -4.8% | -6.2% |
| Q1 FY2024 | $3.06 | $2.09 | +46.5% | -5.8% | -7.8% |
| Q4 FY2024 | $2.65 | $1.98 | +33.6% | +2.2% | +1.2% |